ALPA

Alpa Laboratories Ltd.

NSE: ALPA

BSE: 532878

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

62.02-0.7 (-1.16%)

24 Aug, 9:59 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

42.9 / 100

Value Score

92.0 / 100

Price Momentum Score

24.6 / 100

QVM Score

52.9 / 100

Key Metrics

Market Cap

132.98

P/E (TTM)

30.37

P/B

0.71

P/S (TTM)

1.20

EV/EBITDA

-0.98

CAPE (5Y)

9.13

ROE (TTM)

8.39

ROCE (TTM)

0.67

ROA (TTM)

6.46

Avg 3Y ROE

10.72

Earnings 3Y CAGR

-30.12

Sales 3Y CAGR

4.85

Sales 5Y CAGR

-0.38

Debt/Equity

0.01

Consensus TP

Strong Buy %

Promoter Holding

57.19

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Alpa Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.01 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Expensive and at same valuation levels as industry median P/E

PE TTM of 30.37 indicates that the stock is expensive on a standalone basis. Discount to industry median P/E is modest at -1.07%

What is P/E Ratio?

Median: 30.7

Value 30.37

-0.84752.64

Weak price momentum

Price Momentum score of 24.6 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

24.6 / 100

Low and declining ROE

The company reported low ROE of 8.39% for 12-month ended 30 Jun 2026 and ROE declined by -367 bps from 1 year ago

What is ROE (FY)?

Low but stable operating margin

The company reported low operating margin of 1.13% for 12-month ended 30 Jun 2026 and operating margin declined marginally by -112 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 0.46% for 12-month ended 30 Jun 2026 and the growth was 10.13 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 0.46

-99.6111701.8

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -83.15% for 12-month ended 30 Jun 2026 and the growth was 90.35 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 41.4 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

41.4 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Alpa Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Alpa Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Alpa Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	56.66	56.66	56.66	56.66	56.66	56.66	56.66	56.66	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.19	57.19
Indian Promoter	56.66	56.66	56.66	56.66	56.66	56.66	56.66	56.66	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.29	57.19	57.19
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	0.00	0.14	0.56	0.21	0.14	0.00	0.01	0.01	0.11	0.95	0.50	0.36	0.74	0.35	0.40	0.36	0.35	0.36	0.38	0.42
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	0.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.56	0.21	0.14	0.00	0.00	0.00	0.11	0.95	0.50	0.36	0.74	0.35	0.40	0.36	0.35	0.36	0.38	0.35
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.07
Non-Institution	43.34	43.34	43.34	43.34	43.34	43.34	43.34	43.20	42.15	42.50	42.56	42.71	42.69	42.69	42.60	41.75	42.20	42.35	41.96	42.35	42.31	42.34	42.35	42.35	42.43	42.39
Bodies Corporate	1.63	1.57	1.46	1.47	1.59	1.44	1.50	1.57	1.52	1.43	1.48	1.50	1.41	1.40	1.66	1.50	1.49	1.50	1.61	1.16	0.54	0.68	0.68	0.68	0.79	0.85
Others (incl. Retail) No. of shareholders	41.71 12,130	41.77 12,633	41.88 13,148	41.87 13,691	41.75 13,176	41.90 15,486	41.84 15,524	41.63 16,044	40.63 18,707	41.07 18,734	41.08 18,778	41.21 19,027	41.28 19,078	41.29 18,686	40.94 18,504	40.25 18,619	40.71 18,627	40.85 18,049	40.35 18,802	41.19 19,144	41.77 18,815	41.66 18,798	41.67 18,492	41.67 18,185	41.64 17,852	41.54 17,592

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Alpa Laboratories Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Paresh Chawla Promoter	June-2022	Off Market (Acquisition) 14th Jun 2022	15.92 %	₹ 0.00	3.37 lac	-
SHITUL SHAH Promoter	March-2022	Inter-se Transfer (Acquisition) 5th Mar 2022	2.60 %	₹ 0.00	3.79 lac	₹ 0.00

No corporate action data available.

Company Profile

Overview of Alpa Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterina...

Key personnel

Mr. Sunil Valecha

Additional Non-Executive Independent Director

Jayesh P. Patel

Chief Executive Officer

Bakulesh C. Shah

Chief Financial Officer

Mr. Purushottam R. PatelD

Chairman of the Board

Mr. Paresh M. ChawlaD

Managing Director, Director

Mr. Mahendra Singh ChawlaD

Whole-Time Director

Pravin C. ShahD

Whole Time Director

Mr. Shitul ShahD

Additional Director

View all

Incorporated on

18 Mar 1988

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

01 Aug 2007

Free Float

89,85,590

Website

http://www.alpalabs.in/

Phone no.

+917314294567

Address

33/2, A.B. ROAD, PIGDAMBER RAO, , 453446, India

Frequently Asked Questions

What is the current share price of Alpa Laboratories Ltd.?

The current share price of Alpa Laboratories Ltd. is ₹ 62.02 as of 24 Aug 2026.

What is the market capitalisation of Alpa Laboratories Ltd.?

The market capitalisation of Alpa Laboratories Ltd. stands at ₹ 132.98 Cr.

What is the PE ratio of Alpa Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Alpa Laboratories Ltd. is 30.37 as of the latest trailing twelve months data.

What is the ROE and ROCE of Alpa Laboratories Ltd.?

Alpa Laboratories Ltd. has a Return on Equity (ROE) of 8.39% and a Return on Capital Employed (ROCE) of 0.67% as per the latest financial reports.

What is the 52-week high and low of Alpa Laboratories Ltd.?

The 52-week high of Alpa Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Alpa Laboratories Ltd.?

The dividend yield of Alpa Laboratories Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Alpa Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 0.35%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 41.54% of Alpa Laboratories Ltd. shares.

What sector does Alpa Laboratories Ltd. belong to?

Alpa Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Alpa Laboratories Ltd.?

The beta of Alpa Laboratories Ltd. is 1.04, indicating its price volatility relative to the broader market. Over the past 1 year, Alpa Laboratories Ltd. has delivered an absolute return of -34.24%.

What is the RSI of Alpa Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Alpa Laboratories Ltd. is 39.98, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Alpa Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Alpa Laboratories Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile